FVIIa as used pharmacologically is not TF dependent in hemophilia B mice

Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids

(2012) A. M. Shibeko et al.   BLOOD

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

(2012) Marie-Luise von Brühl et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia

(2011) Lacramioara Ivanciu et al.   NATURE BIOTECHNOLOGY

Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

(2009) Grace M. Thomas et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis

(2008) Y. Buyue et al.   BLOOD

The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface

(2008) C. Weeterings et al.   BLOOD

Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality

(2008) Majed N. Aljamali et al.   JOURNAL OF CLINICAL INVESTIGATION

Further Understanding of Recombinant Activated Factor VII Mode of Action

(2008) Dougald M. Monroe   SEMINARS IN HEMATOLOGY